From PubMed (November 14, 2023)--"Discontinuation of dimethyl fumarate in multiple sclerosis--a nationwide study":https://pubmed...

From PubMed (November 13, 2023)--"Dimethyl fumarate treatment in relapsing remitting MS changes the inflammatory CSF protein pro...

From PubMed (August 20, 2020)--"Progressive multifocal leucoencephalopathy in dimethyl fumarate-treated multiple sclerosis patie...

From Multiple Sclerosis Journal (September 1, 2021)--"Long-term safety and efficacy of dimethyl fumarate for up to 13 years in p...

From Multiple Sclerosis Journal (June 14, 2021)--"Real-world discontinuation rate  of teriflunomide and dimethyl fumarate in mul...

This comes from authors at the US FDA.From PubMed (December 11, 2020)--"Expanding spectrum of opportunistic infections associate...

From Multiple Sclerosis News Today (October 8, 2020),"FDA Approves Lupin's Generic Form of Tecfidera for MS Treatment":https://b...

Tecfidera (dimethyl fumarate) has a "likelihood score" of C ("probable rare cause of clinically apparent liver injury") in the O...

This case seems to be of special interest because dimethyl fumarate-related PML occurred in someone 15 years younger than other ...

This study, published in Neurology, showed Tecfidera to be better than Aubagio at preventing relapses and less likely to be disc...

From PubMed, June 16, 2018--"Real-life persistence and tolerability with dimethyl fumarate" from researchers in Denmark:https://...

PubMed (June 8, 2018) contains an abstract about a study comparing Tecfidera with Gilenya in patients with RRMS, published in Ne...

A Swedish study has found that most of the MS patients on Tecfidera stopped taking it after 2 years, and many changed to Rituxim...

An article in Multiple Sclerosis News Today (August 31, 2017) concerns a study indicating that Tecfidera might be a successful "...

From PubMed, November 10, 2015:QuoteMult Scler J Exp Transl Clin. 2015 Jan-Dec;1. Dimethyl fumarate-associated lymphopenia: Risk...

From MedPage Today, November 13, 2015:QuoteWill 4th PML Case Change Tecfidera Risk Profile?Most recent case occurred in patient ...

From DGNews (DocGuide), November 3, 2015:QuoteDimethyl Fumarate Is Superior to Placebo on Composite Disability Measure: Presente...

From MedPage Today, July 16, 2015:QuoteBiogen Reports Another Tecfidera PML CaseNon-fatal case is the second one for the oral MS...

Presented at the recent annual AAN conference in Washington, DC:Quote[P3.269] Risk of Disease Progression after Starting Dimethy...

The MSAA reports this change in the labeling for Tecfidera (April 28, 2015):QuoteChanges Made to Tecfidera's LabelIn December 20...